Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.45 is 73% below its 5-year average of 9.02, near the low end of its 5-year range (2.11–14.00).
As of the fiscal period ended Tuesday, June 30, 2026. 21.55% below its 12-month average of 3.12.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.45.
QUICK RATIO (ACID-TEST)
2.45
QUICK RATIO (ACID-TEST) AVG TTM
3.12
QUICK RATIO (ACID-TEST) AVG 3Y
6.96
QUICK RATIO (ACID-TEST) AVG 5Y
9.02
QUICK RATIO (ACID-TEST) AVG 10Y
6.66
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-21.55%
CURRENT VS 3Y AVG
-64.77%
CURRENT VS 5Y AVG
-72.84%
CURRENT VS 10Y AVG
-63.22%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-26.95%
vs the sector median at left
Quanterix Corporation
Market Cap
$162.04M
Quick Ratio (Acid-Test)
2.45
TTM Avg
3.12
3Y Avg
6.96
5Y Avg
9.02
Market Cap
$159.80M
Quick Ratio (Acid-Test)
20.14
TTM Avg
22.07
3Y Avg
21.46
5Y Avg
19.43
Market Cap
$159.78M
Quick Ratio (Acid-Test)
13.36
TTM Avg
9.68
3Y Avg
8.92
5Y Avg
10.26
Market Cap
$159.22M
Quick Ratio (Acid-Test)
0.84
TTM Avg
0.97
3Y Avg
0.83
5Y Avg
1.00
Market Cap
$159.14M
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.19
3Y Avg
1.52
5Y Avg
2.42
Market Cap
$165.27M
Quick Ratio (Acid-Test)
7.98
TTM Avg
13.57
3Y Avg
13.59
5Y Avg
18.24
Market Cap
$165.32M
Quick Ratio (Acid-Test)
5.58
TTM Avg
2.96
3Y Avg
5.18
5Y Avg
6.05
Market Cap
$168.10M
Quick Ratio (Acid-Test)
1.25
TTM Avg
2.29
3Y Avg
3.57
5Y Avg
4.16
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $162.04M | 2.45 | 3.12 | 6.96 | 9.02 |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | 20.14 | 22.07 | 21.46 | 19.43 |
| PepGen Inc. (PEPG)vs › | $159.78M | 13.36 | 9.68 | 8.92 | 10.26 |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | 0.84 | 0.97 | 0.83 | 1.00 |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | 1.70 | 1.19 | 1.52 | 2.42 |
| Nkarta, Inc. (NKTX)vs › | $165.27M | 7.98 | 13.57 | 13.59 | 18.24 |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 5.58 | 2.96 | 5.18 | 6.05 |
| Inogen, Inc. (INGN)vs › | $156.22M | 2.34 | 2.40 | 2.87 | 3.55 |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | 1.25 | 2.29 | 3.57 | 4.16 |
| MediWound Ltd. (MDWD)vs › | $168.92M | 2.09 | 2.02 | 3.00 | 2.71 |
Quick Ratio
2.45
Excludes inventory
Current Ratio
3.40
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.45 |
| 2026-03-31 | 2.70 |
| 2025-12-31 | 2.11 |
| 2025-09-30 | 2.31 |
| 2025-06-30 | 6.06 |
| 2025-03-31 | 7.53 |
| 2024-12-31 | 7.88 |
| 2024-09-30 | 9.16 |
| 2024-06-30 | 8.99 |
| 2024-03-31 | 10.57 |
| 2023-12-31 | 9.13 |
| 2023-09-30 | 10.27 |
| 2023-06-30 | 11.30 |
| 2023-03-31 | 13.32 |
| 2022-12-31 | 11.63 |
| 2022-09-30 | 12.90 |
| 2022-06-30 | 10.67 |
| 2022-03-31 | 12.94 |
| 2021-12-31 | 11.54 |
| 2021-09-30 | 14.00 |
| 2021-06-30 | 12.08 |
| 2021-03-31 | 12.75 |
| 2020-12-31 | 5.14 |
| 2020-09-30 | 7.18 |
| 2020-06-30 | 5.32 |
| 2020-03-31 | 6.17 |
| 2019-12-31 | 6.16 |
| 2019-09-30 | 7.00 |
| 2019-06-30 | 4.91 |
| 2019-03-31 | 2.64 |
| 2018-12-31 | 3.09 |
| 2018-09-30 | 3.83 |
| 2018-06-30 | 2.79 |
| 2018-03-31 | 3.13 |
| 2017-12-31 | 4.35 |
| 2017-09-30 | 1.43 |
| 2017-06-30 | 2.21 |
| 2017-03-31 | 2.52 |
| 2016-12-31 | 3.08 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
